medigraphic.com
ISSN 0185-3252 (Print)
Revista de la Asociación Médica del Centro Médico ABC

2012, Number 3

<< Back Next >>

An Med Asoc Med Hosp ABC 2012; 57 (3)

Metabolic syndrome and social support in Mexican patients with type 2 diabetes mellitus

Levin PG, Mota SV, Rivas AL, Rojas JJA

Language: Spanish
References: 21
Page: 185-190
PDF size: 51.77 Kb.


ABSTRACT

Background: Social support may be implied in metabolic syndrome development in patients with type 2 diabetes mellitus. Objetive: The aim of the study is to assess if social support is related to metabolic syndrome in patients with type 2 diabetes mellitus. Material and methods: A cross-sectional study was conducted in 50 type 2 diabetes mellitus patients without chronic complications. Social support was meas­ured using the Diabetes social support self-administered questionnaire. Metabolic syndrome was defined according to the National Cholesterol Educational Program Adult Treatment Panel III guidelines. Data was analyzed using the chi-square test and odds ratios were estimated. Results: The total sample size was 50, from which 64% were female. The mean age of participants was of 54.5 ± 11.5 y.o. The prevalence of metabolic syndrome was 54%. A higher social support level was referred in more than half of the patients (60%). Those who are not reminded of their type 2 diabetes mellitus treatment were found to have 3.864 times greater risk of metabolic syndrome (IC 95%: 1.15-13.00). Conclusions: The results obtained show a relationship between social support and metabolic syndrome. It is important to consider perceived social support to promote metabolic control in patients with type 2 diabetes mellitus.


REFERENCES

  1. Organización Mundial de la Salud. Diabetes. OMS; Nota descriptiva N° 312. EUA; 2008.

  2. Herrera-Díaz LA, Quintero O, Hernández M. Funcionalidad y red de apoyo familiar en pacientes diabéticos tipo 2. Academia 2007; 6 (12): 62-72.

  3. Garay-Sevilla ME, Nava LE, Malacara JM, Huerta R, Díaz de León J, Mena A, Fajardo ME. Adherence to treatment and social support in patients with non-insulin dependent diabetes mellitus. J Diab Comp 1995; 2: 81-86.

  4. Rosland AM, Kieffer E, Israel B, Cofield M, Palmisano G, Sinco B, Spencer M, Heisler M. When is social support important? The association of family support and professional support with specific diabetes self-management behaviors. J Gen Intern Med 2008; 23 (12): 1992-1999.

  5. Isezuo SA, Ezunu E. Demographic and clinical correlates of metabolic syndrome in native African type-2 diabetic patients. J Natl Med Assoc 2005; 97: 557-563.

  6. Song S, Hardisty C. Diagnosing metabolic syndrome in type 2 diabetes: does it matter? Q J Med 2008; 101: 487-491.

  7. National Center for Health Statistics. Plan and Operation of the Third National Health and Nutritional Examination Survey (NHANES III, 1988-1994). Vital Health Stat 1994; 32: 1-407.

  8. Ministerio de Salud, Chile, Encuesta Nacional de Salud año 2003. http://epi.minsal.cl/epi/html/invest/ENS/ENS.htm (Revisión actualizada el 25 de septiembre de 2008).

  9. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ, Valles V, Ríos-Torres JM, Franco A, Olaiz G, Rull JA, Sepúlveda J. High prevalence of the metabolic syndrome in Mexico. Arch Med Res 2004; 35: 76-81.

  10. Reyes-Armua MC, Benítez-Giuggia NM, Lapertosa S. Frecuencia del síndrome metabólico en pacientes con diabetes mellitus tipo 2 en un Servicio de Diabetes de Corrientes. Rev Postgrado VIa Cátedra Méd [revista en Internet]. 2008 [citado 21 feb 2009]; 185: 5-8. Disponible en: http://www.latindex.unam.mx/larga.php?opcion=1&folio=15910.

  11. American Diabetes Association. Standards of medical care in diabetes 2009. (Position Statement). Diabetes Care 2009; 32 (Suppl. 1): S13-S61.

  12. Ley General de Salud. México; Editorial SISTA, 2005: 33.

  13. National Institutes of Health: Third report of the national cholesterol education program on detection, evaluation and treatment of high blood pressure in adults (Adult Treatment Panel III). Final report. NIH, 2002.

  14. Bernard HJ. Diagnóstico y tratamiento clínico por el laboratorio. 9ª edición. Barcelona, España; Editorial Masson-Salvat Medicina, 1997.

  15. Norton K, Whittingham N, Carter L, Kerr D, Gore C. ISAK Estándares internacionales para la valoración antropométrica. 1ª edición. Sydney; UNSW, 2001: 59-67.

  16. Pickering TG, Hall JE, Appel LJ, Falkner BE, Graves J, Hill MN, Jones DW, Kurtz T, Sheps SG, Roccella EJ. Recommendations for blood pressure measurement in humans and experimental animals. Part 1: Blood pressure measurement in humans. A statement for professionals from the subcommittee of professional and public education of the American Heart Association Council on high blood pressure research. Hypertension 2005; 45: 142-161.

  17. Alshkri MM, Elmehdawi RR. Metabolic syndrome among type-2 diabetic patients in Benghazi-Libya: a pilot study. Libyan J Med 2008; 3 (4): 177-180.

  18. González-Torres VM, García-Ramos M, Ramírez-Carrillo F. Calidad de vida del paciente diabético tipo 2 con redes de apoyo familiar. Rev Enferm Inst Méx Seguro Soc 2009; 17 (2): 69-78.

  19. Edelstein J, Linn MW. The influence of the family on control of diabetes. Soc Sci Med 1985; 21 (5): 541-544.

  20. Epple C, Wright VL, Joish VN, Bauer M. The role of active family nutritional support in Navajos’ type 2 diabetes metabolic control. Diabetes Care 2003; 26: 2829-2834.

  21. Zamora-Barrón M, Aguilar-Salinas CA, Gómez-Pérez FJ. Prevalencia de síndrome metabólico en pacientes con hiperlipidemia familiar combinada. Rev Endocrinol Nutr 2004; 12 (1): 46-50.




2020     |     www.medigraphic.com